As a global biopharmaceutical company, we are focused on inventing and developing innovative medicines and vaccines that tackle diseases and improve the lives of people and the well-being of animals around the world.

In addition, we have an important role and responsibility in improving access to medicines, vaccines and quality health care worldwide, thereby helping to reduce the burden of disease around the world. That’s why Access to Health is one of our four corporate responsibility priority areas.

We also recognize that barriers to quality care and medical treatment—such as a lack of trained health care professionals, weak infrastructure, political uncertainty, civil strife, and a shortage of safe water in many parts of the world—make even basic health care delivery difficult at best. These challenges go well beyond what we can directly address alone, so we work in partnership with a range of stakeholders to improve the global health ecosystem.

Access to Health Guiding Principles

Our mission to improve the health and wellness of people around the world by expanding access to medicines and vaccines is one of our company’s five core values. To guide our efforts, we follow our companywide Access to Health Statement of Guiding Principles and our Institutional Business Africa (IBA) Principles, which articulate our approach.

Global Burden of Disease

Our company is addressing an estimated 88 percent of the top 20 global burdens of disease with our products and pipeline.


We believe our role is to work in partnership with local communities, governments, donors, patient organizations, health care professionals, academic institutions, nongovernmental organizations, multilateral organizations and others in the private sector to contribute our expertise and knowledge.

Population Health

Our Global Population Health organization focuses on the complex intersections between the world’s health needs and our company’s priorities and expertise.

Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines and animal health products.

Learn More

Expanding access to medicines and vaccines is a business imperative for optimizing and sustaining our business over the long term. As we strive for continuous improvement and innovation in our access approach, we will reevaluate our policies, practices and programs, as well as the metrics we employ to measure our progress, on an ongoing basis.

Awards & Recognition

We have been recognized for our commitment to improve access to health around the world.


Ranked #2 on the 2018 "Change the World" list for our role in the fight against Ebola

The SDGs and Access to Health

This interactive graphic indicates which of the UN Sustainable Development Goals (SDGs) most closely align with our mission to save and improve lives.

Learn More
1 /